ACURA PHARMACEUTICALS, INC Research: A Comprehensive Company Overview
ACURA PHARMACEUTICALS, INC, a pioneering name in the pharmaceutical industry, has carved out a remarkable niche through its innovative approaches and dedication to combating opioid abuse. This detailed company summary delves into the various facets of ACURA PHARMACEUTICALS, INC, providing an extensive overview that is perfect for individuals considering purchasing a more detailed report from our service, AskCyborg.com.
Company Overview: ACURA PHARMACEUTICALS, INC
Pro stress-test →Founded in [Year], ACURA PHARMACEUTICALS, INC has been at the forefront of pharmaceutical innovation, particularly focusing on developing abuse-deterrent formulations (ADFs) of opioids and other medications. The company is headquartered in Palatine, Illinois, and is publicly traded on the NASDAQ under the ticker symbol ACUR.
Product Portfolio
Pro stress-test →ACURA PHARMACEUTICALS, INC offers a range of products designed to deter abuse, misuse, and diversion of prescription medications. Their flagship product, Oxaydo, is an immediate-release oxycodone formulation that incorporates their proprietary Aversion Technology. Other notable products include Nexafed, a pseudoephedrine formulation designed to prevent illicit methamphetamine production.
Leadership and Management Team
Pro stress-test →The leadership at ACURA PHARMACEUTICALS, INC comprises seasoned professionals with extensive experience in the pharmaceutical industry. Key members include:
- Robert B. Jones – President and CEO
- Peter A. Clemens – Chief Financial Officer
- Michael S. DeStefano – Vice President of Operations
Financial Overview of ACURA PHARMACEUTICALS, INC
ACURA PHARMACEUTICALS, INC has shown a resilient financial performance over the years. Recent financial reports indicate a stable revenue stream, with a significant portion attributed to their patented technologies and strategic partnerships. Key financial metrics include:
- Annual Revenue: $[X] million
- Net Income: $[X] million
- Market Capitalization: $[X] million
Marketing Strategies
ACURA PHARMACEUTICALS, INC employs a multi-faceted marketing strategy that includes direct-to-consumer advertising, strategic partnerships with other pharmaceutical companies, and educational campaigns aimed at healthcare providers. Their focus on abuse-deterrent formulations is a key differentiator in their marketing efforts.
Market Overview and Competitors
The pharmaceutical market is highly competitive, with numerous players vying for market share. ACURA PHARMACEUTICALS, INC faces competition from both large pharmaceutical companies and smaller biotech firms. Key competitors include Purdue Pharma, Teva Pharmaceuticals, and Collegium Pharmaceutical.
Sales Strategies
ACURA PHARMACEUTICALS, INC utilizes a diverse range of sales channels to distribute their products, including direct sales to healthcare providers, partnerships with pharmaceutical distributors, and online sales platforms. Their sales strategy is heavily focused on educating prescribers and pharmacists about the benefits of their abuse-deterrent formulations.
Technologies Utilized
At the core of ACURA PHARMACEUTICALS, INC’s innovation is their proprietary Aversion Technology, which is designed to deter common methods of abuse such as chewing, snorting, or injecting medications. This technology is a cornerstone of their product offerings and sets them apart in the market.
HR Practices
ACURA PHARMACEUTICALS, INC values its employees and fosters a collaborative work environment. Their HR practices include competitive compensation packages, continuous professional development programs, and a strong emphasis on work-life balance.
Corporate Responsibility
Corporate social responsibility (CSR) is a key component of ACURA PHARMACEUTICALS, INC’s business model. The company is committed to ethical practices and actively participates in community outreach programs aimed at reducing opioid abuse and supporting addiction recovery initiatives.
Future Plans
Looking ahead, ACURA PHARMACEUTICALS, INC aims to expand its product portfolio and explore new markets. They are investing in research and development to create next-generation abuse-deterrent technologies and are exploring strategic partnerships to enhance their market presence.
Get the full report on ACURA PHARMACEUTICALS, INC by subscribing